MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maren, T. H.
Right arrow Articles by Wistrand, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maren, T. H.
Right arrow Articles by Wistrand, P. J.

Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme

TH Maren, GC Wynns and PJ Wistrand

University of Florida College of Medicine, Department of Pharmacology and Therapeutics, Gainesville 32610.

The carbonic anhydrase (CA) isozyme (IV) in microsomes is thought to have a dominant role in secretory processes. Using microsomes from bovine kidney and lung (which had the same activity), we have measured the Km and kcat for CO2 hydration and compared these numbers with those for CA I (red blood cells and gut), CA II (red blood cells and secretory cells), and CA III (muscle). For kidney CA IV, Km is 10 mM and kcat is 170,000 sec-1 at 0 degree, approaching the rate for CA II but much greater than those for CA I or III. The Ki values for 11 sulfonamides with CA IV were measured and in all cases showed less binding (averaging 17-fold) than to CA II. This is the result of reduction of the association rate constants (k(on)), whereas the dissociation constants of the drug-enzyme complexes (k(off) are similar between CA II and IV. Based on these data, full physiological effects may be expected when inhibition of CA IV is about 99%. Anion inhibition of CA IV is similar to that of CA II and less than that of CA I or CA III. Data are compatible with the proposed role of CA IV in physiological events, i.e., HCO3- formation and secretion at one cell border and H+ separation and excretion at the other.

Volume 44, Issue 4, pp. 901-905, 10/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Physiol.Home page
L. J. Teppema, H. Bijl, B. M. Gourabi, and A. Dahan
The carbonic anhydrase inhibitors methazolamide and acetazolamide have different effects on the hypoxic ventilatory response in the anaesthetized cat
J. Physiol., July 15, 2006; 574(2): 565 - 572.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
A. J. Esbaugh and B. L. Tufts
Tribute to R. G. Boutilier: Evidence of a high activity carbonic anhydrase isozyme in the red blood cells of an ancient vertebrate, the sea lamprey Petromyzon marinus
J. Exp. Biol., April 1, 2006; 209(7): 1169 - 1178.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
A. J. Esbaugh, S. F. Perry, M. Bayaa, T. Georgalis, J. Nickerson, B. L. Tufts, and K. M. Gilmour
Cytoplasmic carbonic anhydrase isozymes in rainbow trout Oncorhynchus mykiss: comparative physiology and molecular evolution
J. Exp. Biol., May 15, 2005; 208(10): 1951 - 1961.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Purkerson and G. J. Schwartz
Expression of membrane-associated carbonic anhydrase isoforms IV, IX, XII, and XIV in the rabbit: induction of CA IV and IX during maturation
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1256 - R1263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. J. Schwartz, A. M. Kittelberger, R. H. Watkins, and M. A. O'Reilly
Carbonic anhydrase XII mRNA encodes a hydratase that is differentially expressed along the rabbit nephron
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F399 - F410.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. F. KIWULL-SCHÖNE, L. J. TEPPEMA, and P. J. KIWULL
Low-dose Acetazolamide Does Affect Respiratory Muscle Function in Spontaneously Breathing Anesthetized Rabbits
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 478 - 483.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
C.-K. Tong, L. P. Brion, C. Suarez, and M. Chesler
Interstitial Carbonic Anhydrase (CA) Activity in Brain Is Attributable to Membrane-Bound CA Type IV
J. Neurosci., November 15, 2000; 20(22): 8247 - 8253.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
I. Puscas, M. Coltau, M. Baican, and G. Domuta
Omeprazole Has a Dual Mechanism of Action: It Inhibits Both H+K+ATPase and Gastric Mucosa Carbonic Anhydrase Enzyme in Humans (In Vitro and In Vivo Experiments)
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 530 - 534.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. D. Hurt, C. Tu, P. J. Laipis, and D. N. Silverman
Catalytic Properties of Murine Carbonic Anhydrase IV
J. Biol. Chem., May 23, 1997; 272(21): 13512 - 13518.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. H. Maren, C. W. Conroy, G. C. Wynns, and D. R. Godman
Renal and Cerebrospinal Fluid Formation Pharmacology of a High Molecular Weight Carbonic Anhydrase Inhibitor
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 98 - 104.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Stams, S. K. Nair, T. Okuyama, A. Waheed, W. S. Sly, and D. W. Christianson
Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-A resolution
PNAS, November 26, 1996; 93(24): 13589 - 13594.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics